• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a):在小儿缺血性卒中和血栓形成中起作用吗?

Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?

机构信息

Department of Hematology and Oncology, Cook Children's Medical Center, 1500 Cooper St, Fort Worth, TX, 76104, USA.

Department of Research Data Science and Analytics, Cook Children's Medical Center, 801 Seventh Avenue, Fort Worth, TX, 76104, USA.

出版信息

Curr Atheroscler Rep. 2023 Jun;25(6):299-307. doi: 10.1007/s11883-023-01102-5. Epub 2023 May 9.

DOI:10.1007/s11883-023-01102-5
PMID:37160656
Abstract

PURPOSE OF REVIEW

The goal of this paper is to describe the current understanding of lipoprotein (a) (Lp(a)), clinical practice guidelines, and the potential pathophysiological mechanisms that appear to increase the risk of cardiovascular and thromboembolic events, specifically within the pediatric population.

RECENT FINDINGS

The proatherogenic and pro-thrombotic properties of Lp(a) may increase the risk of atherothrombotic disease. In adults, atherosclerotic plaques increase thrombotic risk, but antifibrinolytic and proinflammatory properties appear to have an important role in children. Although it is not well established in neonates, recent studies indicate the risk of incident thrombosis and ischemic stroke are approximately fourfold higher in children with elevated Lp(a) which also increases their risk of recurrent events. Despite this higher risk, Pediatric Lp(a) screening guidelines continue to vary among different medical societies and countries. The inconsistency is likely related to inconclusive evidence outside of observational studies and the lack of specific therapies for children with elevated levels. Additional research is needed to improve understanding of the pro-thrombotic mechanisms of Lp(a), appropriate screening guidelines for Lp(a) in the pediatric population, and to elucidate the short and long term effects of elevated Lp(a) on the risk of pediatric thrombosis and stroke.

摘要

综述目的

本文旨在描述脂蛋白 (a)(Lp(a))的现有认识、临床实践指南,以及似乎增加心血管和血栓栓塞事件风险的潜在病理生理机制,特别是在儿科人群中。

最近的发现

Lp(a) 的促动脉粥样硬化和促血栓形成特性可能会增加动脉粥样硬化性疾病的风险。在成年人中,动脉粥样硬化斑块会增加血栓形成的风险,但抗纤维蛋白溶解和促炎特性似乎在儿童中具有重要作用。尽管在新生儿中尚未得到很好的证实,但最近的研究表明,Lp(a)升高的儿童发生血栓事件和缺血性中风的风险大约高四倍,并且他们的复发风险也更高。尽管存在这种更高的风险,但儿科 Lp(a) 筛查指南在不同的医学协会和国家之间仍存在差异。这种不一致可能与观察性研究之外的证据不明确以及缺乏针对高 Lp(a)水平儿童的特定治疗方法有关。需要进一步研究以提高对 Lp(a) 的促血栓形成机制、儿科人群中 Lp(a) 的适当筛查指南以及阐明升高的 Lp(a) 对儿科血栓形成和中风风险的短期和长期影响的理解。

相似文献

1
Lipoprotein (a): Does It Play a Role in Pediatric Ischemic Stroke and Thrombosis?脂蛋白(a):在小儿缺血性卒中和血栓形成中起作用吗?
Curr Atheroscler Rep. 2023 Jun;25(6):299-307. doi: 10.1007/s11883-023-01102-5. Epub 2023 May 9.
2
Is lipoprotein(a) a risk factor for ischemic stroke and venous thromboembolism?脂蛋白(a)是缺血性中风和静脉血栓栓塞的危险因素吗?
Clin Res Cardiol Suppl. 2019 Apr;14(Suppl 1):28-32. doi: 10.1007/s11789-019-00101-8.
3
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?脂蛋白(a):动脉血栓形成管理中的缺失罪魁祸首?
J Cell Physiol. 2018 Apr;233(4):2966-2981. doi: 10.1002/jcp.26050. Epub 2017 Jul 11.
4
Predictors of cholesterol and lipoprotein(a) testing in children with arterial ischemic stroke.动脉缺血性卒中患儿胆固醇和脂蛋白(a)检测的预测因素。
J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2405-13. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.013. Epub 2014 Aug 28.
5
The association between lipoprotein(a) levels and ischemic stroke in children: A case-control study.脂蛋白(a)水平与儿童缺血性脑卒中的相关性:病例对照研究。
Pediatr Blood Cancer. 2024 Oct;71(10):e31236. doi: 10.1002/pbc.31236. Epub 2024 Jul 31.
6
Case report of male child with elevated lipoprotein (a) leading to acute ischemic stroke.脂蛋白(a)升高导致急性缺血性卒中的男童病例报告。
J Clin Apher. 2017 Dec;32(6):574-578. doi: 10.1002/jca.21525. Epub 2017 Jan 31.
7
Lipoprotein (a) and cerebrovascular disease.脂蛋白(a)与脑血管病。
J Int Med Res. 2024 Jul;52(7):3000605241264182. doi: 10.1177/03000605241264182.
8
Frequency & factors associated with elevated lipoprotein-a among Ghanaian stroke survivors.加纳中风幸存者脂蛋白(a)升高的频率及相关因素。
J Neurol Sci. 2024 Jan 15;456:122839. doi: 10.1016/j.jns.2023.122839. Epub 2023 Dec 12.
9
Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.脂蛋白(a)对卒中复发的影响在 LDL-C(低密度脂蛋白)和炎症水平较低时减弱。
Stroke. 2022 Aug;53(8):2504-2511. doi: 10.1161/STROKEAHA.121.034924. Epub 2022 Apr 12.
10
Lipoprotein(a): Its relevance to the pediatric population.脂蛋白(a):其与儿科人群的相关性。
J Clin Lipidol. 2015 Sep-Oct;9(5 Suppl):S57-66. doi: 10.1016/j.jacl.2015.07.006. Epub 2015 Jul 21.

引用本文的文献

1
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening.重新审视心血管风险:脂蛋白(a)筛查的新作用。
Am J Prev Cardiol. 2025 Feb 14;21:100945. doi: 10.1016/j.ajpc.2025.100945. eCollection 2025 Mar.
2
Clinical characteristics and risk factors of cardiovascular disease in systemic lupus erythematosus patients.系统性红斑狼疮患者心血管疾病的临床特征及危险因素
Heart Vessels. 2024 Dec 24. doi: 10.1007/s00380-024-02508-0.
3
Lipoprotein(a) throughout life in women.女性一生中的脂蛋白(a)

本文引用的文献

1
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.脂蛋白(a)基因型与阿司匹林用于心血管事件一级预防的关系。
J Am Coll Cardiol. 2022 Oct 4;80(14):1287-1298. doi: 10.1016/j.jacc.2022.07.027.
2
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.脂蛋白(a)与动脉粥样硬化性心血管疾病及主动脉瓣狭窄:欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2022 Oct 14;43(39):3925-3946. doi: 10.1093/eurheartj/ehac361.
3
Prevalence of Atherosclerotic Risk Factors Among Children and Young Adults With Arterial Ischemic Stroke.
Am J Prev Cardiol. 2024 Oct 29;20:100885. doi: 10.1016/j.ajpc.2024.100885. eCollection 2024 Dec.
4
Lipoprotein (a) and cerebrovascular disease.脂蛋白(a)与脑血管病。
J Int Med Res. 2024 Jul;52(7):3000605241264182. doi: 10.1177/03000605241264182.
动脉缺血性脑卒中患儿和青年人群中动脉粥样硬化危险因素的流行情况。
JAMA Neurol. 2022 Sep 1;79(9):901-910. doi: 10.1001/jamaneurol.2022.2077.
4
Cerebral sinovenous thrombosis in children: clinical presentation, locations, and acquired and inherited prothrombotic risk factors.儿童脑静脉窦血栓形成:临床表现、部位及获得性和遗传性血栓形成前危险因素。
Turk J Pediatr. 2021;63(6):1028-1037. doi: 10.24953/turkjped.2021.06.011.
5
Pediatric Acute Ischemic Stroke by Age-Group: A Systematic Review and Meta-Analysis of Published Studies and Hospitalization Records.儿童急性缺血性脑卒中的年龄组分析:系统综述和已发表研究及住院记录的荟萃分析。
Neuroepidemiology. 2021;55(5):331-341. doi: 10.1159/000518281. Epub 2021 Aug 17.
6
Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.脂蛋白(a)升高与儿童、年轻人及老年人的中风风险
Eur Heart J. 2021 Jun 7;42(22):2197-2200. doi: 10.1093/eurheartj/ehab251.
7
The impact of race and ethnicity on lipoprotein(a) levels and cardiovascular risk.种族和民族对脂蛋白(a)水平和心血管风险的影响。
Curr Opin Lipidol. 2021 Jun 1;32(3):163-166. doi: 10.1097/MOL.0000000000000753.
8
Recurrent stroke: the role of thrombophilia in a large international pediatric stroke population.复发性中风:血栓形成倾向在一个大型国际儿童中风群体中的作用
Haematologica. 2019 Oct;104(10):2116. doi: 10.3324/haematol.2019.234666.
9
Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.在人体中,用反义寡核苷酸强力降低血浆脂蛋白(a)不会影响体外纤溶。
J Lipid Res. 2019 Dec;60(12):2082-2089. doi: 10.1194/jlr.P094763. Epub 2019 Sep 24.
10
Statin therapy increases lipoprotein(a) levels.他汀类药物治疗会升高脂蛋白(a)水平。
Eur Heart J. 2020 Jun 21;41(24):2275-2284. doi: 10.1093/eurheartj/ehz310.